SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

25.33p
   
  • Change Today:
    -0.77p
  • 52 Week High: 27.00
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 232.98m
  • Volume: 668,630
  • Market Cap: £59.02m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.19% above the market average98.19% above the market average98.19% above the market average98.19% above the market average98.19% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
76.17% above the market average76.17% above the market average76.17% above the market average76.17% above the market average76.17% above the market average
78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average
Price Book Ratio
96.74% below the market average96.74% below the market average96.74% below the market average96.74% below the market average96.74% below the market average
90.48% below the sector average90.48% below the sector average90.48% below the sector average90.48% below the sector average90.48% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
83.23% above the market average83.23% above the market average83.23% above the market average83.23% above the market average83.23% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Price Chg 3m
94.84% above the market average94.84% above the market average94.84% above the market average94.84% above the market average94.84% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
64.92% above the market average64.92% above the market average64.92% above the market average64.92% above the market average64.92% above the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Momentum 20
62.90% above the market average62.90% above the market average62.90% above the market average62.90% above the market average62.90% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
82.39% below the market average82.39% below the market average82.39% below the market average82.39% below the market average82.39% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
60.03% below the market average60.03% below the market average60.03% below the market average60.03% below the market average60.03% below the market average
20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
77.74% below the market average77.74% below the market average77.74% below the market average77.74% below the market average77.74% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
Operating Profit Loss
62.82% below the market average62.82% below the market average62.82% below the market average62.82% below the market average62.82% below the market average
8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
76.07% below the market average76.07% below the market average76.07% below the market average76.07% below the market average76.07% below the market average
60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average
Cash
64.08% below the market average64.08% below the market average64.08% below the market average64.08% below the market average64.08% below the market average
65.96% below the sector average65.96% below the sector average65.96% below the sector average65.96% below the sector average65.96% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 25.33p
Change Today -0.77p
% Change -2.94 %
52 Week High 27.00
52 Week Low 8.50
Volume 668,630
Shares Issued 232.98m
Market Cap £59.02m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.34% below the market average72.34% below the market average72.34% below the market average72.34% below the market average72.34% below the market average
91.49% below the sector average91.49% below the sector average91.49% below the sector average91.49% below the sector average91.49% below the sector average
Price Trend
96.76% above the market average96.76% above the market average96.76% above the market average96.76% above the market average96.76% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
48.59% above the market average48.59% above the market average48.59% above the market average48.59% above the market average48.59% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average

SBTX Dividends

No dividends found

Trades for 28-Apr-2025

Time Volume / Share Price
16:22 18,889 @ 25.25p
16:06 10,000 @ 25.48p
16:04 500 @ 25.48p
15:41 2,000 @ 25.25p
15:35 2,000 @ 25.25p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page